• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人工智能建立的用于鉴别诊断肾上腺皮质癌和腺瘤的组织微小RNA组合

Tissue miRNA Combinations for the Differential Diagnosis of Adrenocortical Carcinoma and Adenoma Established by Artificial Intelligence.

作者信息

Turai Péter István, Herold Zoltán, Nyirő Gábor, Borka Katalin, Micsik Tamás, Tőke Judit, Szücs Nikolette, Tóth Miklós, Patócs Attila, Igaz Peter

机构信息

Department of Endocrinology, ENS@T Research Center of Excellence, Faculty of Medicine, Semmelweis University, H-1083 Budapest, Hungary.

Department of Internal Medicine and Oncology, Faculty of Medicine, Semmelweis University, H-1083 Budapest, Hungary.

出版信息

Cancers (Basel). 2022 Feb 11;14(4):895. doi: 10.3390/cancers14040895.

DOI:10.3390/cancers14040895
PMID:35205648
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8870702/
Abstract

The histological analysis of adrenal tumors is difficult and requires great expertise. Tissue microRNA (miRNA) expression is distinct between benign and malignant tumors of several organs and can be useful for diagnostic purposes. MiRNAs are stable and their expression can be reliably reproduced from archived formalin-fixed, paraffin-embedded (FFPE) tissue blocks. Our purpose was to assess the potential applicability of combinations of literature-based miRNAs as markers of adrenocortical malignancy. Archived FFPE tissue samples from 10 adrenocortical carcinoma (ACC), 10 adrenocortical adenoma (ACA) and 10 normal adrenal cortex samples were analyzed in a discovery cohort, while 21 ACC and 22 ACA patients were studied in a blind manner in the validation cohort. The expression of miRNA was determined by RT-qPCR. Machine learning and neural network-based methods were used to find the best performing miRNA combination models. To evaluate diagnostic applicability, ROC-analysis was performed. We have identified three miRNA combinations ( + + ; + + and + + ) as unexpectedly good predictors to determine adrenocortical malignancy with sensitivity and specificity both of over 90%. These miRNA panels can supplement the histological examination of removed tumors and could even be performed from small volume adrenal biopsy samples preoperatively.

摘要

肾上腺肿瘤的组织学分析难度较大,需要专业知识。组织微小RNA(miRNA)表达在多个器官的良性和恶性肿瘤之间存在差异,可用于诊断。miRNA稳定,其表达可从存档的福尔马林固定、石蜡包埋(FFPE)组织块中可靠重现。我们的目的是评估基于文献的miRNA组合作为肾上腺皮质恶性肿瘤标志物的潜在适用性。在一个发现队列中分析了来自10例肾上腺皮质癌(ACC)、10例肾上腺皮质腺瘤(ACA)和10例正常肾上腺皮质样本的存档FFPE组织样本,而在验证队列中以盲法研究了21例ACC和22例ACA患者。通过RT-qPCR测定miRNA的表达。使用基于机器学习和神经网络的方法来寻找性能最佳的miRNA组合模型。为评估诊断适用性,进行了ROC分析。我们确定了三种miRNA组合(++;+++和+++)作为意外良好的预测指标,用于确定肾上腺皮质恶性肿瘤,敏感性和特异性均超过90%。这些miRNA检测板可补充切除肿瘤的组织学检查,甚至可在术前从小体积肾上腺活检样本中进行检测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7909/8870702/40b4744ecad7/cancers-14-00895-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7909/8870702/84fa24e4e2d1/cancers-14-00895-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7909/8870702/40b4744ecad7/cancers-14-00895-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7909/8870702/84fa24e4e2d1/cancers-14-00895-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7909/8870702/40b4744ecad7/cancers-14-00895-g002.jpg

相似文献

1
Tissue miRNA Combinations for the Differential Diagnosis of Adrenocortical Carcinoma and Adenoma Established by Artificial Intelligence.基于人工智能建立的用于鉴别诊断肾上腺皮质癌和腺瘤的组织微小RNA组合
Cancers (Basel). 2022 Feb 11;14(4):895. doi: 10.3390/cancers14040895.
2
MicroRNA Expression Profiling in Adrenal Myelolipoma.肾上腺髓质脂肪瘤中的 microRNA 表达谱分析。
J Clin Endocrinol Metab. 2018 Sep 1;103(9):3522-3530. doi: 10.1210/jc.2018-00817.
3
Comparison of plasma and urinary microRNA-483-5p for the diagnosis of adrenocortical malignancy.血浆和尿 microRNA-483-5p 用于诊断肾上腺皮质癌的比较。
J Biotechnol. 2019 May 20;297:49-53. doi: 10.1016/j.jbiotec.2019.03.017. Epub 2019 Mar 30.
4
Analysis of circulating microRNAs in adrenocortical tumors.肾上腺皮质肿瘤中循环 microRNAs 的分析。
Lab Invest. 2014 Mar;94(3):331-9. doi: 10.1038/labinvest.2013.148. Epub 2013 Dec 16.
5
Analysis of circulating extracellular vesicle-associated microRNAs in cortisol-producing adrenocortical tumors.分析皮质醇分泌性肾上腺皮质肿瘤中外泌体相关 microRNAs 的循环变化。
Endocrine. 2018 Feb;59(2):280-287. doi: 10.1007/s12020-017-1506-z. Epub 2018 Jan 3.
6
Exploratory Circular RNA Profiling in Adrenocortical Tumors.肾上腺皮质肿瘤中的环状RNA探索性分析
Cancers (Basel). 2022 Sep 2;14(17):4313. doi: 10.3390/cancers14174313.
7
Heterogeneous circulating miRNA profiles of PBMAH.PBMAH 的异质循环 miRNA 谱。
Front Endocrinol (Lausanne). 2022 Dec 13;13:1073328. doi: 10.3389/fendo.2022.1073328. eCollection 2022.
8
Next-generation sequencing reveals microRNA markers of adrenocortical tumors malignancy.下一代测序揭示肾上腺皮质肿瘤恶性程度的微小RNA标志物。
Oncotarget. 2017 Jul 25;8(30):49191-49200. doi: 10.18632/oncotarget.16788.
9
Differential MicroRNA Expression Between Gastric Cancer Tissue and Non-cancerous Gastric Mucosa According to Status.根据状态分析胃癌组织与非癌性胃黏膜之间的微小RNA差异表达
J Cancer Prev. 2017 Mar;22(1):33-39. doi: 10.15430/JCP.2017.22.1.33. Epub 2017 Mar 30.
10
Circulating miRNA Expression Profiling in Primary Aldosteronism.原发性醛固酮增多症中循环miRNA表达谱分析
Front Endocrinol (Lausanne). 2019 Oct 29;10:739. doi: 10.3389/fendo.2019.00739. eCollection 2019.

引用本文的文献

1
miRNA Expression Profiling in G1 and G2 Pancreatic Neuroendocrine Tumors.G1和G2级胰腺神经内分泌肿瘤中的微小RNA表达谱分析
Cancers (Basel). 2024 Jul 13;16(14):2528. doi: 10.3390/cancers16142528.
2
RCOR1 is targeted by miR-23b-3p to modulate growth, colony formation, migration, and invasion of prostate cancer cells.RCOR1是miR-23b-3p的作用靶点,可调节前列腺癌细胞的生长、集落形成、迁移和侵袭。
Int J Clin Exp Pathol. 2024 Feb 15;17(2):29-38. doi: 10.62347/MNSQ2960. eCollection 2024.
3
Diagnostic Challenges during Inflammation and Cancer: Current Biomarkers and Future Perspectives in Navigating through the Minefield of Reactive versus Dysplastic and Cancerous Lesions in the Digestive System.

本文引用的文献

1
How to Differentiate Benign from Malignant Adrenocortical Tumors?如何鉴别肾上腺皮质肿瘤的良恶性?
Cancers (Basel). 2021 Aug 30;13(17):4383. doi: 10.3390/cancers13174383.
2
Key MicroRNA's and Their Targetome in Adrenocortical Cancer.肾上腺皮质癌中的关键微小RNA及其靶标组
Cancers (Basel). 2020 Aug 6;12(8):2198. doi: 10.3390/cancers12082198.
3
Non-Coding RNAs in Adrenocortical Cancer: From Pathogenesis to Diagnosis.肾上腺皮质癌中的非编码RNA:从发病机制到诊断
炎症与癌症期间的诊断挑战:当前生物标志物以及消化系统中反应性、发育异常和癌性病变雷区导航的未来展望
Int J Mol Sci. 2024 Jan 19;25(2):1251. doi: 10.3390/ijms25021251.
4
Artificial intelligence in diabetes mellitus and endocrine diseases - what can we expect?人工智能在糖尿病和内分泌疾病中的应用——我们能期待什么?
Nat Rev Endocrinol. 2023 Jul;19(7):375-376. doi: 10.1038/s41574-023-00852-1.
5
Pharmacological impact of microRNAs in head and neck squamous cell carcinoma: Prevailing insights on molecular pathways, diagnosis, and nanomedicine treatment.微小RNA在头颈部鳞状细胞癌中的药理作用:关于分子途径、诊断及纳米医学治疗的当前见解
Front Pharmacol. 2023 May 3;14:1174330. doi: 10.3389/fphar.2023.1174330. eCollection 2023.
6
The cAMP-signaling cancers: Clinically-divergent disorders with a common central pathway.cAMP 信号通路相关癌症:具有共同核心通路的临床差异显著的疾病。
Front Endocrinol (Lausanne). 2022 Oct 13;13:1024423. doi: 10.3389/fendo.2022.1024423. eCollection 2022.
7
New Insights in the Genetics and Genomics of Adrenocortical Tumors and Pheochromocytomas.肾上腺皮质肿瘤和嗜铬细胞瘤的遗传学与基因组学新见解
Cancers (Basel). 2022 Feb 21;14(4):1094. doi: 10.3390/cancers14041094.
Cancers (Basel). 2020 Feb 17;12(2):461. doi: 10.3390/cancers12020461.
4
miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis.miRNAs 作为疾病的生物标志物:关于其在诊断和预后中作用的最新发现。
Cells. 2020 Jan 23;9(2):276. doi: 10.3390/cells9020276.
5
Machine learning algorithm validation with a limited sample size.机器学习算法在有限样本量下的验证。
PLoS One. 2019 Nov 7;14(11):e0224365. doi: 10.1371/journal.pone.0224365. eCollection 2019.
6
Apoptosis regulation in adrenocortical carcinoma.肾上腺皮质癌中的细胞凋亡调控
Endocr Connect. 2019 May 1;8(5):R91-R104. doi: 10.1530/EC-19-0114.
7
Comparison of plasma and urinary microRNA-483-5p for the diagnosis of adrenocortical malignancy.血浆和尿 microRNA-483-5p 用于诊断肾上腺皮质癌的比较。
J Biotechnol. 2019 May 20;297:49-53. doi: 10.1016/j.jbiotec.2019.03.017. Epub 2019 Mar 30.
8
microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma.microRNA-431 作为促肾上腺皮质癌化疗增敏剂和药物活性增强剂。
Oncologist. 2019 Jun;24(6):e241-e250. doi: 10.1634/theoncologist.2018-0849. Epub 2019 Mar 27.
9
miR-483-5p Targets MKNK1 to Suppress Wilms' Tumor Cell Proliferation and Apoptosis In Vitro and In Vivo.miR-483-5p 通过靶向调控 MKNK1 抑制肾母细胞瘤细胞的增殖和凋亡。
Med Sci Monit. 2019 Feb 24;25:1459-1468. doi: 10.12659/MSM.913005.
10
Adrenal biopsy: performance and use.肾上腺活检:操作与应用。
Minerva Endocrinol. 2019 Sep;44(3):288-300. doi: 10.23736/S0391-1977.19.02969-9. Epub 2019 Feb 6.